These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. DEEPSEN: a convolutional neural network based method for super-enhancer prediction. Bu H; Hao J; Gan Y; Zhou S; Guan J BMC Bioinformatics; 2019 Dec; 20(Suppl 15):598. PubMed ID: 31874597 [TBL] [Abstract][Full Text] [Related]
3. Super-enhancers in transcriptional regulation and genome organization. Wang X; Cairns MJ; Yan J Nucleic Acids Res; 2019 Dec; 47(22):11481-11496. PubMed ID: 31724731 [TBL] [Abstract][Full Text] [Related]
4. Super enhancer lncRNAs: a novel hallmark in cancer. Song P; Han R; Yang F Cell Commun Signal; 2024 Apr; 22(1):207. PubMed ID: 38566153 [TBL] [Abstract][Full Text] [Related]
5. Super-Enhancers and Their Parts: From Prediction Efforts to Pathognomonic Status. Vasileva AV; Gladkova MG; Ashniev GA; Osintseva ED; Orlov AV; Kravchuk EV; Boldyreva AV; Burenin AG; Nikitin PI; Orlova NN Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542080 [TBL] [Abstract][Full Text] [Related]
6. Super-enhancers in cancer. Thandapani P Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876 [TBL] [Abstract][Full Text] [Related]
7. Targeting Super-Enhancers for Disease Treatment and Diagnosis. Shin HY Mol Cells; 2018 Jun; 41(6):506-514. PubMed ID: 29754476 [TBL] [Abstract][Full Text] [Related]
8. The emerging role of super enhancer-derived noncoding RNAs in human cancer. Wang Y; Nie H; He X; Liao Z; Zhou Y; Zhou J; Ou C Theranostics; 2020; 10(24):11049-11062. PubMed ID: 33042269 [TBL] [Abstract][Full Text] [Related]
9. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies. Dębek S; Juszczyński P Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188697. PubMed ID: 35150791 [TBL] [Abstract][Full Text] [Related]
10. [ Super-enhancers. Are they regulators of regulatory genes of development and cancer?]. Didych DA; Tyulkina DV; Pleshkan VV; Alekseenko IV; Sverdlov ED Mol Biol (Mosk); 2015; 49(6):915-22. PubMed ID: 26710770 [TBL] [Abstract][Full Text] [Related]
11. Metabolic reprogramming directed by super-enhancers in tumors: An emerging landscape. Zhou Z; Li J; Ousmane D; Peng L; Yuan X; Wang J Mol Ther; 2024 Mar; 32(3):572-579. PubMed ID: 38327048 [TBL] [Abstract][Full Text] [Related]
12. A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer. Kelly MR; Wisniewska K; Regner MJ; Lewis MW; Perreault AA; Davis ES; Phanstiel DH; Parker JS; Franco HL Nat Commun; 2022 Jul; 13(1):4247. PubMed ID: 35869079 [TBL] [Abstract][Full Text] [Related]
13. Super-enhancers complexes zoom in transcription in cancer. Wang M; Chen Q; Wang S; Xie H; Liu J; Huang R; Xiang Y; Jiang Y; Tian D; Bian E J Exp Clin Cancer Res; 2023 Jul; 42(1):183. PubMed ID: 37501079 [TBL] [Abstract][Full Text] [Related]
14. The molecular understanding of super-enhancer dysregulation in cancer. Yoshino S; Suzuki HI Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms. Jia Q; Chen S; Tan Y; Li Y; Tang F Exp Mol Med; 2020 May; 52(5):713-723. PubMed ID: 32382065 [TBL] [Abstract][Full Text] [Related]
17. [Research progress of super enhancer in cancer]. Wu ZQ; Mi ZY Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784 [TBL] [Abstract][Full Text] [Related]
18. The structural and functional roles of CTCF in the regulation of cell type-specific and human disease-associated super-enhancers. Shin HY Genes Genomics; 2019 Mar; 41(3):257-265. PubMed ID: 30456521 [TBL] [Abstract][Full Text] [Related]
19. Contribution of transposable elements and distal enhancers to evolution of human-specific features of interphase chromatin architecture in embryonic stem cells. Glinsky GV Chromosome Res; 2018 Mar; 26(1-2):61-84. PubMed ID: 29335803 [TBL] [Abstract][Full Text] [Related]